NCT00671541View on ClinicalTrials.gov

Nasospore Stent For Use in Enodscopic Sinus Surgery

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Chronic Sinusitis
Interventions
DRUG

Merogel Nasal Stent and Nasopore Stent

Merogel Nasal Stent and Nasopore Stent

DRUG

Nasopore Stent and either Gentamycin or Bacitracin

Nasopore Stent with Bacitracin (100,000 units in 10cc(NSS)or Gentamycin(80mg in 10cc NSS)

Trial Locations (1)

01805

Lahey Clinic, Inc, Burlington

Sponsors

Lead Sponsor

Lahey Clinic
All Listed Sponsors
lead

Lahey Clinic

OTHER

NCT00671541 - Nasospore Stent For Use in Enodscopic Sinus Surgery | Biotech Hunter | Biotech Hunter